Browse > Article
http://dx.doi.org/10.1007/s10059-009-0167-z

Ligand-Independent Activation of the Androgen Receptor by Insulin-Like Growth Factor-I and the Role of the MAPK Pathway in Skeletal Muscle Cells  

Kim, Hye Jin (Department of Exercise Science, College of Health Sciences, Ewha Womans University)
Lee, Won Jun (Department of Exercise Science, College of Health Sciences, Ewha Womans University)
Abstract
In this study, the roles of the p38 MAPK, ERK1/2 and JNK signaling pathway in IGF-I-induced AR induction and activation were examined. C2C12 cells were treated with IGF-I in the absence or presence of various inhibitors of p38 MAPK (SB203580), ERK1/2 (PD98059), and JNK (SP600125). Inhibition of the MAPK pathway with SB203580, PD98059, or SP600125 significantly decreased IGF-I-induced AR phosphorylation and total AR protein expression. IGF-I-induced nuclear fraction of total AR and phosphorylated AR were significantly inhibited by SB203580, PD98059, or SP600125. Furthermore, IGF-I-induced AR mRNA and skeletal ${\alpha}-actin$ mRNA were blocked by those inhibitors in dose-dependent manner. Confocal images showed that IGF-I-induced AR nuclear translocation from cytosol was significantly blocked by SB203580, PD98059, or SP600125, suggesting that the MAPK pathway regulates IGF-I-induced AR nuclear localization in skeletal muscle cells. The present results suggest that the MAPK pathways are required for the ligand-independent activation of AR by IGF-I in C2C12 skeletal muscle cells.
Keywords
androgen receptor; insulin-like growth factor-I; ligand-independent mechanism; mitogen-activated protein kinase; steroid receptor;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
1 Carlson, C.J., Fan, Z., Gordon, S.E., and Booth, F.W. (2001). Time course of the MAPK and PI3-kinase response within 24 h of skeletal muscle overload. J. Appl. Physiol. 91, 2079-2087   DOI
2 Chen, Y., Zajac, J.D., and MacLean, H.E. (2005). Androgen regulation of satellite cell function. J. Endocrinol. 186, 21-31   DOI   ScienceOn
3 Fanzani, A., Colombo, F., Giuliani, R., Preti, A., and Marchesini, S. (2006). Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. FEBS J. 273, 3709-3721   DOI   ScienceOn
4 Lu, S., Liu, M., Epner, D.E., Tsai, S.Y., and Tsai, M.J. (1999). Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol. 13, 376-384   DOI   ScienceOn
5 Roy, A.K., Tyagi, R.K., Song, C.S., Lavrovsky, Y., Ahn, S.C., Oh, T.S., and Chatterjee, B. (2001). Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann. NY Acad. Sci. 949, 44-57   DOI   PUBMED   ScienceOn
6 Wannenes, F., Caprio, M., Gatta, L., Fabbri, A., Bonini, S., and Moretti, C. (2008). Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Mol. Cell. Endocrinol. 292, 11-19   DOI   PUBMED   ScienceOn
7 Wen, Y., Hu, M.C., Makino, K., Spohn, B., Bartholomeusz, G., Yan, D.H., and Hung, M.C. (2000). HER-2/neu promotes androgenindependent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 60, 6841-6845   PUBMED
8 Wu, J.D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., and Plymate, S.R. (2006). Interaction of IGF-signaling and the androgen receptor in prostate cancer progression. J. Cell. Biochem. 99, 392-401   DOI   ScienceOn
9 Xu, L., Glass, C.K., and Rosenfeld, M.G. (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147   DOI   ScienceOn
10 Taneja, S.S., Ha, S., Swenson, N.K., Huang, H.Y., Lee, P., Melamed, J., Shapiro, E., Garabedian, M.J., and Logan, S.K. (2005). Cellspecific regulation of androgen receptor phosphorylation in vivo. J. Biol. Chem. 280, 40916-40924   DOI   ScienceOn
11 Adams, G.R., and Haddad, F. (1996). The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J. Appl. Physiol. 81, 2509-2516   DOI
12 Keren, A., Tamir, Y., and Bengal, E. (2006). The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252, 224-230   DOI   ScienceOn
13 Kim, H.J., and Lee, W.J. (2009). Insulin-like growth factor-I induces androgen receptor activation in differentiating C2C12 skeletal muscle cells. Mol. Cells 28, 189-194   DOI   PUBMED   ScienceOn
14 Lin, H.K., Wang, L., Hu, Y.C., Altuwaijri, S., and Chang, C. (2002). Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21, 4037-4048   DOI   ScienceOn
15 Mora, G.R., and Mahesh, V.B. (1999). Autoregulation of androgen receptor at the translational level: testosterone induces accumulation of androgen receptor mRNA in the rat ventral prostate polyribosomes. Steroids 64, 587-591   DOI   ScienceOn
16 Butler, A.A., Yakar, S., Gewolb, I.H., Karas, M., Okubo, Y., and LeRoith, D. (1998). Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Mol. Biol. 121, 19-26   DOI   ScienceOn
17 Lin, H.K., Yeh, S., Kang, H.Y., and Chang, C. (2001). Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. USA 98, 7200-7205   DOI   ScienceOn
18 Lee, W.J., Thompson, R.W., McClung, J.M., and Carson, J.A. (2003b). Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle. Am. J. Physiol. 285, R1076-R1085
19 Ueda, T., Mawji, N.R., Bruchovsky, N., and Sadar, M.D. (2002). Ligand-independent activation of the androgen receptor by interleukin- 6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J. Biol. Chem. 227, 38087-38094
20 Tyagi, R.K., Lavrovsky, Y., Ahn, S.C., Song, S.C., Chatterjee, B., and Roy, A.K. (2000). Dynamics of intercellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol. 14, 1162-1174   DOI   ScienceOn
21 Lee, W.J., McClung, J., Hand, G.A., and Carson, J.A. (2003a). Overload-induced androgen receptor expression in the aged hindlimb receiving nandrolone decanoate. J. Appl. Physiol. 94, 1153-1161   DOI   ScienceOn
22 Meng, D., Shi, X., Jiang, B.H., and Fang, J. (2007). Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 42, 1651-1660   DOI   ScienceOn
23 Haddad, F., and Adams, G.R. (2004). Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles. J. Appl. Physiol. 96, 203-210   DOI
24 Culig, Z., Hobisch, A., Cronauer, M.V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478   PUBMED
25 McLellan, A.S., Kealey, T., and Langlands, K. (2006). An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells. Am. J. Physiol. 291, C300-C307   DOI   ScienceOn
26 Lee, D.K. (2002). Androgen receptor enhances myogenin expression and accelerates differentiation. Biochem. Biophys. Res. Commun. 294, 408-413   DOI   PUBMED   ScienceOn